Novel Molecular Targets for Immune Surveillance of Hepatocellular Carcinoma

SIMPLE SUMMARY: Hepatocellular Carcinoma (HCC) is a common and aggressive cancer with limited treatment options. Approximately half of all patients with HCC receive systemic therapy during their disease course, particularly in the advanced stages of the disease. Immunotherapy has been paradigm-shift...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerra, Pietro, Martini, Andrea, Pontisso, Patrizia, Angeli, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377787/
https://www.ncbi.nlm.nih.gov/pubmed/37509293
http://dx.doi.org/10.3390/cancers15143629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377787/
https://www.ncbi.nlm.nih.gov/pubmed/37509293
http://dx.doi.org/10.3390/cancers15143629

Ejemplares similares